Answers are grounded in this paper and cite their sources.
Microfluidic technologies improve therapeutic delivery by synthesizing nanoparticles effectively, indicating their potential in overcoming biological barriers.
Microfluidic technologies have revolutionized the synthesis of nanocarriers for drug and gene delivery, providing unparalleled precision and efficiency in the production of therapeutic nanoparticles.
No takes yet. Share an insight, caveat, or question.
Gharatape et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: